Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-007261
Filing Date
2024-10-21
Accepted
2024-10-21 17:27:02
Documents
55
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR AUGUST 2024 cannabis_i10q-083124.htm   iXBRL 10-Q 452812
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER cannabisbio_ex3100.htm EX-31 10661
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 USC SECTION 1350 cannabisbio_ex3200.htm EX-32 3491
  Complete submission text file 0001683168-24-007261.txt   3082333

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbih-20240831.xsd EX-101.SCH 28717
5 XBRL CALCULATION FILE cbih-20240831_cal.xml EX-101.CAL 38156
6 XBRL DEFINITION FILE cbih-20240831_def.xml EX-101.DEF 78575
7 XBRL LABEL FILE cbih-20240831_lab.xml EX-101.LAB 244529
8 XBRL PRESENTATION FILE cbih-20240831_pre.xml EX-101.PRE 198335
57 EXTRACTED XBRL INSTANCE DOCUMENT cannabis_i10q-083124_htm.xml XML 294894
Mailing Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 333-146758 | Film No.: 241384238
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)